IU lands $8.5 million grant to renovate Riley hospital
Gift will be used for a pediatric research facility to better identify how genetic and environmental factors contribute to
diseases in children.
Gift will be used for a pediatric research facility to better identify how genetic and environmental factors contribute to
diseases in children.
West Lafayette-based Bioanalytical Systems Inc. has promoted Anthony S. Chilton to CEO following the retirement of top executive
Richard M. Shepperd earlier this year.
U.S. companies, including Eli Lilly, amassed at least $1 trillion in foreign profits not taxed in the U.S. as of the end of
last year. That cumulative total increased 70 percent over three years.
Community Health Systems plans to build a five-story, 250-bed hospital at the corner of U.S. 6 and Indiana 49 in Vaparaiso.
Construction is expected to cost about $225 million.
CNO Financial Group Inc., known as Conseco Inc. until May 11, has become almost the polar opposite of what it was under flashy co-founder
Steve Hilbert. Instead of high-octane growth driven by merger deals, CNO Financial has returned to profitability
by selling low-dollar products and emphasizing low-cost operations.
Senate Appropriations Chairman Luke Kenley, R-Noblesville, said the costs to Indiana for health reform will be so great that
the state should consider the drastic step of creating another option to Medicaid.
Construction of a new Wishard Memorial Hospital was hailed as a great legacy for Indianapolis as a formal groundbreaking was
held for the $754 million project.
Joe Guzman is a co-founder of Indianapolis-based Ascend USA, the new trade adopted after Guzman merged his
benefits brokerage, Benefits Strategies Inc., with benefits business Steven Goodin. The eight-person firm expects to hire
as many 15 new employees in the next year. Those workers will help Ascend diversify from health benefits into brokering commercial
insurance products.
The U.S. Food and Drug Administration last week pushed its self-declared deadline for rendering an approval decision on the
drug Bydureon to Oct. 22. The previous deadline was in March.
As physician mergers increase in Indianapolis, a new study has determined that quality at large, multispecialty practices is at
least 5 percent higher and costs are 3.6 percent lower than at small group practices.
Carmel-based life and health insurer is now CNO Financial Group Inc. to reflect what company officers call a “transformation”
of the once-troubled firm.
The U.S. health overhaul’s mandate that insurers spend 80 percent of premiums on medical care may
need to be loosened
to keep companies from quitting the market for people who buy coverage on their own, state regulators said.
The health law passed by Congress in March will force insurers like WellPoint to give rebates to customers next year if the
companies don’t meet the medical-spending minimums.
CEO of Indianapolis-based health insurer wrote to Obama on Sunday to rebut the president’s criticism that WellPoint seeks
out breast cancer patients to cancel their policies.
The lawsuit filed this week in Marion Superior Court claims Clarian Health charges uninsured patients—or those receiving
treatments not covered by their insurance—unreasonably high prices.
Indianapolis-based drugmaker Eli Lilly and Co. is on course to cut 5,500 jobs by the end of 2011 in a bid to eliminate $1
billion in annual expenses.
Elanco Animal Health chief Jeff Simmons predicts that consumers will opt for food made cheaper by using
Elanco’s productivity-enhancing drugs over pricier organic and locally grown products. But, as a hedge,
he has Elanco developing products to help organic farmers, too.
Bloomington led the nation as the No. 1 small city in medical devices and equipment.
The deal included a $296 million criminal fine, but no charges against executives who failed to properly report problems with the company's defibrillators.
Groundbreaking will be held May 16 to mark start of construction on center to be built on 300-acre campus.